Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
62 /100
HIGH RISK
Score updated Oct 13, 2026

GLTO — Damora Therapeutics, Inc. Dilution Risk Tracker

Track GLTO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLTO — Get alerts when the score changes →

As of October 13, 2026, Damora Therapeutics, Inc. (GLTO) has a DilutionWatch DilutionScore of 62/100, rated HIGH dilution risk. Damora Therapeutics, Inc. has a market capitalization of $1.73B, 61.74M shares outstanding, 67 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
0
📊 Float Risk
100
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration model 10%
• Score in HIGH risk zone (62/100)
🔔 Track GLTO — Get forecast alerts →

Market Data

Market Cap$1.73B
Shares Outstanding61.74M
Float1.05M
Cash$576.50M
Debt$72.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore62/100DilutionWatch score record
Shares Outstanding61.74MVerified float table or market cache
Public Float1.05MVerified float table or market cache
Market Cap$1.73BMarket data cache
Cash Runway181.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

67 institutional holders · 59.68M shares
#1 FMR LLC 9.05M shares
#2 Fairmount Funds Management LLC 8.71M shares
#3 Remedium Capital Partners, LLC 4.09M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-02-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GLTO Dilution Snapshot

Damora Therapeutics, Inc. (GLTO) has a DilutionScore of 62/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GLTO's DilutionScore has held steady at 62/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202662/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track GLTO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GLTO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GLTO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations